B of A Securities Downgrades Doximity to Underperform, Lowers Price Target to $20
B of A Securities downgrades Doximity to Underperform with a $20 price target.
B of A Securities analyst Allen Lutz downgrades Doximity (NYSE: DOCS ) from Buy to Underperform and lowers the price target from $38 to $20.